ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Operating income

KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967)

Market cap
¥455.2B
P/E ratio
43.4x
Kobayashi Pharmaceutical makes healthcare products and consumer goods like deodorizers and oral care items, serving domestic and international markets through 40 subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Dec 31, 202514,923-39.97%
Dec 31, 202424,860-3.57%
Dec 31, 202325,780-3.33%
Dec 31, 202226,669+2.32%
Dec 31, 202126,065+0.47%
Dec 31, 202025,943-1.56%
Dec 31, 201926,355+0.25%
Dec 31, 201826,289+14.67%
Dec 31, 201722,925+31.68%
Dec 31, 201617,409-4.66%
Mar 31, 201618,260+1.91%
Mar 31, 201517,917

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat